Now showing items 1-1 of 1

    • Gene Expression Signatures and Response to Imatinib Mesylate in Gastrointestinal Stromal Tumor 

      Ochs, Michael F.; Rink, Lori; Skorobogatko, Yuliya; Kossenkov, Andrew; Belinsky, Martin G.; Pajak, Thomas; Heinrich, Michael C.; Blanke, Charles D.; Mehren, Margaret von; Eisenberg, Burton; Godwin, Andrew K. (American Association for Cancer Research, 2009)
      Purpose Despite initial efficacy of imatinib mesylate (IM) in most gastrointestinal stromal tumor (GIST) patients, many experience primary/secondary drug resistance. Therefore, clinical management of GIST may benefit from ...